D.E. Shaw & Co’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
D.E. Shaw & Co's EXEL Position: Q1 2026 in Review
D.E. Shaw & Co increased its Exelixis (EXEL) stake by 94% in Q1 2026, buying an estimated $74.9M and bringing the position to 3,603,063 shares worth $155M. The position accounts for 0.09% of the portfolio, ranked #249.
D.E. Shaw & Co first reported a position in EXEL in Q2 2013 and has held it in 50 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- D.E. Shaw & Co held 3,603,063 shares of Exelixis worth $155M as of Q1 2026.
- D.E. Shaw & Co bought 1,743,058 Exelixis shares in Q1 2026, an estimated $74.9M.
- Exelixis made up 0.09% of D.E. Shaw & Co's portfolio in Q1 2026, its #249 holding.
- D.E. Shaw & Co first reported a position in Exelixis in Q2 2013 and has held it in 50 quarters since.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.